Intrinsic and extrinsic effects of mafG deficiency on hematopoietic recovery following bone marrow transplant

Experimental Hematology

Volumn 38, Issue 12, 2010, Pages 1251-1260

  Li, Xiao Miao ^a   Hu, Zhongbo ^a   Zafar, Abu Bakr ^a   Jorgensen, Marda L ^b   Bungert, Jorg ^b   Slayton, William ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NOTCH1 RECEPTOR; PROTEIN BACH 2; TRANSCRIPTION FACTOR MAFG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL COUNT; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; GRAFT RECIPIENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; LEUKOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN WEIGHT; THROMBOCYTE FUNCTION; WILD TYPE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BONE MARROW TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; LEUKOCYTE COUNT; MAFG TRANSCRIPTION FACTOR; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; PLATELET COUNT; RECEPTOR, NOTCH1; REPRESSOR PROTEINS; SPLEEN;

MUS;

EID: 78549292747     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.08.005     Document Type: Article

References (21)

1. Onodera K., Shavit J.A., Motohashi H., Yamamoto M., Engel J.D. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J 2000, 19:1335-1345.
2. Catani L., Vianelli N., Amabile M., et al. Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis. Leukemia 2002, 16:1773-1781.
3. Motohashi H., Katsuoka F., Shavit J.A., Engel J.D., Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 2000, 103:865-875.
4. Shavit J.A., Motohashi H., Onodera K., Akasaka J., Yamamoto M., Engel J.D. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev 1998, 12:2164-2174.
5. Hadjantonakis A.K., Gertsenstein M., Ikawa M., Okabe M., Nagy A. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998, 76:79-90.
6. Vintersten K., Monetti C., Gertsenstein M., et al. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 2004, 40:241-246.
7. Li X.M., Hu Z., Sola-Visner M., et al. Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsets. Exp Hematol 2007, 35:1567-1579.
8. Nakorn T.N., Miyamoto T., Weissman I.L. Characterization of mouse clonogenic megakaryocyte progenitors. Proc Natl Acad Sci U S A 2003, 100:205-210.
9. Slayton W.B., Wainman D.A., Li X.M., et al. Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 2005, 23:1400-1408.
10. Sharma Y., Astle C.M., Harrison D.E. Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function. Exp Hematol 2007, 35:214-220.
11. Passegue E., Jamieson C.H., Ailles L.E., Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc Natl Acad Sci U S A 2003, 100:11842-11849.
12. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988, 241:58-62.
13. Morrison S.J., Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994, 1:661-673.
14. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A 2001, 98:14541-14546.
15. Muto A., Hoshino H., Madisen L., et al. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer. EMBO J 1998, 17:5734-5743.
16. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006, 7:678-689.
17. Feyerabend T.B., Terszowski G., Tietz A., et al. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms. Immunity 2009, 30:67-79.
18. Radtke F., Wilson A., Mancini S.J., MacDonald H.R. Notch regulation of lymphocyte development and function. Nat Immunol 2004, 5:247-253.
19. Mercher T., Cornejo M.G., Sears C., et al. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 2008, 3:314-326.
20. Katsuoka F., Motohashi H., Ishii T., Aburatani H., Engel J.D., Yamamoto M. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol Cell Biol 2005, 25:8044-8051.
21. Chan K., Han X.D., Kan Y.W. An important function of Nrf2 in combating oxidative stress:d etoxification of acetaminophen. Proc Natl Acad Sci U S A 2001, 98:4611-4616.